These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

536 related items for PubMed ID: 31985807

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
    Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR.
    Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease.
    Liem RI, Lanzkron S, D Coates T, DeCastro L, Desai AA, Ataga KI, Cohen RT, Haynes J, Osunkwo I, Lebensburger JD, Lash JP, Wun T, Verhovsek M, Ontala E, Blaylark R, Alahdab F, Katabi A, Mustafa RA.
    Blood Adv; 2019 Dec 10; 3(23):3867-3897. PubMed ID: 31794601
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain.
    Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E.
    Blood Adv; 2020 Jun 23; 4(12):2656-2701. PubMed ID: 32559294
    [Abstract] [Full Text] [Related]

  • 7. American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation.
    Kanter J, Liem RI, Bernaudin F, Bolaños-Meade J, Fitzhugh CD, Hankins JS, Murad MH, Panepinto JA, Rondelli D, Shenoy S, Wagner J, Walters MC, Woolford T, Meerpohl JJ, Tisdale J.
    Blood Adv; 2021 Sep 28; 5(18):3668-3689. PubMed ID: 34581773
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adverse events of red blood cell transfusions in patients with sickle cell disease.
    Rollins MR, Chou ST.
    Transfus Apher Sci; 2022 Oct 28; 61(5):103557. PubMed ID: 36064527
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Challenges in the treatment and prevention of delayed hemolytic transfusion reactions with hyperhemolysis in sickle cell disease patients.
    Dean CL, Maier CL, Chonat S, Chang A, Carden MA, El Rassi F, McLemore ML, Stowell SR, Fasano RM.
    Transfusion; 2019 May 28; 59(5):1698-1705. PubMed ID: 30848512
    [Abstract] [Full Text] [Related]

  • 16. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
    Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN).
    Transfusion; 2013 Apr 28; 53(4):704-9. PubMed ID: 22804353
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NL, Meier ER.
    Transfusion; 2016 Jul 28; 56(7):1707-15. PubMed ID: 26997031
    [Abstract] [Full Text] [Related]

  • 19. Alloimmunization in sickle cell anemia in the era of extended red cell typing.
    O'Suoji C, Liem RI, Mack AK, Kingsberry P, Ramsey G, Thompson AA.
    Pediatr Blood Cancer; 2013 Sep 28; 60(9):1487-91. PubMed ID: 23508932
    [Abstract] [Full Text] [Related]

  • 20. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
    Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP.
    Pediatrics; 2003 Jun 28; 111(6 Pt 1):e661-5. PubMed ID: 12777582
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.